Cervical cancer, which fashion designer Liz Lange fought, is rising among women adults, as per the 2024 AACR Cancer Progress Report.
New research, published in the journal Frontiers in Cancer Control and Society, has found that Midwestern states may have a dramatically increased risk of getting certain types of cancers, due to the ...
As Bruce Springsteen’s wife Patti Scialfa has been battling early-stage multiple myeloma, a rare and incurable type of blood cancer, since 2018, the iconic singer-songwriter is offering all of his ...
Legendary model Christie Brinkley is modeling on magazine covers again and it’s clear to see she’s been staying active, eating health, and taking care of herself as she ages. Her efforts reminds us ...
Clinical Trial Finder: Search for clinical trials that fit your profile ...
Former President Jimmy Carter is just a couple of weeks away from turning 100, defying doctor’s expectations when he began hospice care in February 2023. Carter’s home state of Georgia is celebrating ...
CNN chief correspondent John King, 61, who first joined the network in 1997, has been persevering for over 15 years since his MS diagnosis — and managing symptoms for 25, as he continues coverage into ...
It’s wonderful to see Prince William and his beloved wife Kate Middleton, Catherine, the Princess of Wales, maintaining a strong bond throughout her cancer battle. Middleton was recently spotted ...
The 2024 American Association for Cancer Research (AACR) Cancer Progress Report has revealed that breast and prostate cancer incidence has surpassed lung cancer in the United States. Meanwhile, the ...
New data from The Kinsey Institute at Indiana University, partnered with sexual wellbeing company the Lovehoney Group and its Womanizer brand, has found that 36.2 percent of menopausal women found ...
'Had I not gone to the hospital when I did, I would've at the very least been completely paralyzed,' says Simon Cummings of the traumatic incident Simon Cummings, at 49 years old, was close to ...
The Food and Drug Administration (FDA) has just approved Novartis’ Kisqali (ribociclib) in combination with an aromatase inhibitor as treatment for people with HR+/HER2- stage II and III early breast ...